Latest news

Today’s most relevant clinical news
in minutes.

The New England Journal of MedicineThe LancetJAMABMJPubMed

Stay on top of what matters in your therapy area.

ScioWire curates daily clinical news from sources that matter to you every day:

  • Leading KOL voices in your field
  • Latest peer-reviewed clinical study publications
  • Up-to-date guideline changes
  • Latest medicines approval
7Medical
stories
Stories
Swipe for news in brief.
CardiologyNEJM
20% MACE reduction sustained at 4 years
Studies essentials
The latest clinical studies, fast.
+18mo
Median OS gain
Infographics
Visual-first, bite-size stories.
Practice-changing guidance
Guidelines
Practice-changing guide in a nutshell.
KOL interviewsPremium
Expert sessions and gated material for verified members.
Explore your therapy area

Every specialty breaks down into focused topics. Pick your specialties, then fine-tune the topics that shape your feed.

Coronary artery diseaseHeart failureArrhythmias & electrophysiologyInterventional & structural cardiologyValvular heart diseaseCardiac imagingPreventive cardiology, hypertension & lipid managementAcute cardiovascular care
Breast cancerLung & thoracic cancersGastrointestinal cancerGenitourinary cancersGynaecological cancersHead & neck cancerSkin cancer & melanomaHaematological cancers
AsthmaCOPDInterstitial lung diseaseLung cancerSleep apnoeaRespiratory infectionPulmonary hypertension
StrokeEpilepsyMultiple sclerosis & neuroimmunologyParkinson’s disease & movement disordersDementia & cognitive declineHeadache & migraineNeuromuscular diseaseSleep disorders
Depression & depressive disordersBipolar disorderSchizophrenia & psychosisAnxiety & OCDNeurodevelopmental disorders (ADHD, autism)Trauma & PTSDEating disordersPsychopharmacology
AlcoholOpioids & opioid agonist treatmentStimulants (cocaine, amphetamines)CannabisTobacco & nicotineNew psychoactive substancesHarm reductionDual diagnosis
PeriodontologyEndodonticsImplantologyOral surgeryOrthodonticsOral medicine & pathology
Inflammatory bowel diseaseLiver & biliary diseasesDigestive oncologyOesophageal & gastric diseasesPancreatic diseasesNeurogastroenterology & motility disordersColorectal cancer & screeningDigestive endoscopy
Prostate cancerBladder & kidney cancerBenign prostatic hyperplasiaKidney stonesIncontinence & pelvic floor disordersAndrology & fertilityNeuro-urology
PsoriasisAtopic dermatitis & eczemaAcne & rosaceaSkin cancerAutoimmune skin diseasesHair & nail disordersUrticaria
Frailty & sarcopeniaFalls & mobility impairmentDeliriumDementia & cognitive declineIncontinence urinary & faecalPolypharmacy & deprescribingMultimorbidity & assessmentEnd-of-life & palliative care
Contraception & fertilityMenopauseEndometriosis & fibroidsPregnancy & obstetricsPCOSBreast & cervical screeningUrogynaecology
DiabetesObesity & weight managementThyroidPituitary & adrenal disordersBone & calciumLipids & metabolic syndromeReproductive endocrinology & PCOS
LymphomaLeukaemiaMyelomaMyelodysplastic & myeloproliferative disordersAnaemias & red cell disordersHaemoglobinopathiesThrombosis & bleeding disordersCell therapy & transplantation
Acute kidney injuryChronic kidney diseaseDiabetic kidney diseaseDialysisElectrolyte & acid-base disordersGlomerular diseaseKidney transplantation
Rheumatoid arthritisSpondyloarthritis & psoriatic arthritisLupus & connective tissue diseasesVasculitisOsteoarthritisGout & crystal arthritisOsteoporosis
Retinal & macular diseasesDiabetic eye diseaseGlaucomaCataract & refractive surgeryCornea & external eye diseasesUveitis & intraocular inflammationPaediatric ophthalmology & strabismusNeuro-ophthalmology

Your feed, your preferences. Content that stays in your control.

Choose your therapy area or content type. Select how often you see third party content.

Six months free on launch

Sign-up opens at launch.

9:41
Manage third party content
Third party content

AI at the core, an editor on every piece.

ScioWire runs on a credibility engine that generates accurate summaries from trusted sources, each verified by a medical editor before they hit your feed.

NEJM
LANCET
BMJ
Sources
Journals, guidelines, KOLs, congresses and regulators
AI engine
Drafts a structured version complete with references
EA
SL
KF
Editor review
A medical editor validates every piece
Publication
Clinically relevant news updates curated for your chosen therapy areas
You
Your feed, your therapy areas, your rules

Go beyond the feed: add your own local sources, browse our library, or request a source specific to you.Coming soon

Six months free on launch

Sign-up opens at launch.

ScioWire is an independent publisher of clinically relevant news, built on transparency.

The mission is simple: give HCPs control over what they read and what content reaches them. Because trust between HCPs and the healthcare industry starts with putting you first.

Here’s how we do it

  • Native ScioWire news are sourced from peer-reviewed publications, guidelines, KOL opinions and regulators.
    NEJMThe LancetBMJJAMAPubMed
  • Third-party content is clearly labelled, every time.
  • Trust by design starts with empowering you to control relevant content by therapy area and media format.
Sabine Louët
CEO
Sabine Louët
Karla Fallon
Chief Content Officer
Karla Fallon
Sandra Lafforgue
Project Manager
Sandra Lafforgue
Eloise Aston
Medical Writer - Editor
Eloise Aston

Free gets you everything. Premium gives you control.

The core feed is always free for HCPs. Premium adds deeper control over your sources, formats, frequency of exposure to third-party content and email digests. Nothing essential ever sits behind a paywall.

Core
Free
 
Sign up for free today
  • ScioWire native clinical news, guidelines and CME included
  • Feed curated for relevance to your therapy areas
  • Personalised by content type
  • Full closed network commenting with verified peers
  • Weekly email digest
  • Third-party content clearly labelled
Premium Coming soon
€24 / month
7-day free trial
Everything in Core, plus
  • Control over third-party content frequency, by therapy area and content type
  • External source aggregation: add your own trusted sources via RSS; society blogs, regulator feeds, country communities
  • Weekly email digest available
Six months free on launch

Sign-up opens at launch.